chr17-81510993-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001614.5(ACTG1):​c.918C>T​(p.Tyr306Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.801 in 1,613,832 control chromosomes in the GnomAD database, including 519,901 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 44684 hom., cov: 32)
Exomes 𝑓: 0.81 ( 475217 hom. )

Consequence

ACTG1
NM_001614.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 2.79

Publications

39 publications found
Variant links:
Genes affected
ACTG1 (HGNC:144): (actin gamma 1) Actins are highly conserved proteins that are involved in various types of cell motility and in maintenance of the cytoskeleton. Three main groups of actin isoforms have been identified in vertebrate animals: alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. Actin gamma 1, encoded by this gene, is a cytoplasmic actin found in all cell types. Mutations in this gene are associated with DFNA20/26, a subtype of autosomal dominant non-syndromic sensorineural progressive hearing loss and also with Baraitser-Winter syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
ACTG1 Gene-Disease associations (from GenCC):
  • Baraitser-winter syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss 20
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Baraitser-Winter cerebrofrontofacial syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 17-81510993-G-A is Benign according to our data. Variant chr17-81510993-G-A is described in ClinVar as Benign. ClinVar VariationId is 44150.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.79 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTG1NM_001614.5 linkc.918C>T p.Tyr306Tyr synonymous_variant Exon 5 of 6 ENST00000573283.7 NP_001605.1 P63261
ACTG1NM_001199954.3 linkc.918C>T p.Tyr306Tyr synonymous_variant Exon 5 of 6 NP_001186883.1 P63261
ACTG1NR_037688.3 linkn.990C>T non_coding_transcript_exon_variant Exon 5 of 7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTG1ENST00000573283.7 linkc.918C>T p.Tyr306Tyr synonymous_variant Exon 5 of 6 5 NM_001614.5 ENSP00000458435.1 P63261

Frequencies

GnomAD3 genomes
AF:
0.762
AC:
115797
AN:
151986
Hom.:
44671
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.631
Gnomad AMI
AF:
0.871
Gnomad AMR
AF:
0.739
Gnomad ASJ
AF:
0.814
Gnomad EAS
AF:
0.858
Gnomad SAS
AF:
0.792
Gnomad FIN
AF:
0.835
Gnomad MID
AF:
0.737
Gnomad NFE
AF:
0.821
Gnomad OTH
AF:
0.777
GnomAD2 exomes
AF:
0.788
AC:
198064
AN:
251344
AF XY:
0.793
show subpopulations
Gnomad AFR exome
AF:
0.629
Gnomad AMR exome
AF:
0.690
Gnomad ASJ exome
AF:
0.804
Gnomad EAS exome
AF:
0.877
Gnomad FIN exome
AF:
0.837
Gnomad NFE exome
AF:
0.816
Gnomad OTH exome
AF:
0.800
GnomAD4 exome
AF:
0.805
AC:
1177071
AN:
1461728
Hom.:
475217
Cov.:
90
AF XY:
0.806
AC XY:
585879
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.626
AC:
20955
AN:
33474
American (AMR)
AF:
0.698
AC:
31198
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.810
AC:
21174
AN:
26134
East Asian (EAS)
AF:
0.822
AC:
32619
AN:
39700
South Asian (SAS)
AF:
0.788
AC:
67942
AN:
86256
European-Finnish (FIN)
AF:
0.835
AC:
44524
AN:
53314
Middle Eastern (MID)
AF:
0.750
AC:
4320
AN:
5760
European-Non Finnish (NFE)
AF:
0.815
AC:
906344
AN:
1111978
Other (OTH)
AF:
0.795
AC:
47995
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
16575
33150
49726
66301
82876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20860
41720
62580
83440
104300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.762
AC:
115848
AN:
152104
Hom.:
44684
Cov.:
32
AF XY:
0.763
AC XY:
56731
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.631
AC:
26169
AN:
41466
American (AMR)
AF:
0.739
AC:
11276
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.814
AC:
2825
AN:
3470
East Asian (EAS)
AF:
0.858
AC:
4432
AN:
5166
South Asian (SAS)
AF:
0.793
AC:
3816
AN:
4814
European-Finnish (FIN)
AF:
0.835
AC:
8838
AN:
10588
Middle Eastern (MID)
AF:
0.724
AC:
213
AN:
294
European-Non Finnish (NFE)
AF:
0.821
AC:
55841
AN:
68014
Other (OTH)
AF:
0.778
AC:
1644
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1341
2682
4022
5363
6704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.790
Hom.:
22027
Bravo
AF:
0.748
Asia WGS
AF:
0.776
AC:
2697
AN:
3478
EpiCase
AF:
0.813
EpiControl
AF:
0.811

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Oct 15, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Tyr306Tyr in Exon 05 of ACTG1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 35.7% (1333/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs1139405). -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal dominant nonsyndromic hearing loss 20 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 20;C3281235:Baraitser-winter syndrome 2 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Baraitser-winter syndrome 2 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
3.1
DANN
Benign
0.94
PhyloP100
2.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1139405; hg19: chr17-79478019; COSMIC: COSV59509939; COSMIC: COSV59509939; API